Family Cord Blood Banking Act
Latest Action
Referred to the House Committee on Ways and Means.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Family Cord Blood Banking Act (H.R. 8882) is a bill introduced in the 118th Congress aimed at addressing issues related to family cord blood banking. The bill was referred to the House Committee on Ways and Means but did not advance further and is currently classified as failed or expired. There is no official summary or full text available to provide detailed provisions or objectives. The bill falls under the policy area of taxation, suggesting it may involve tax-related measures concerning family cord blood banking services or expenses.
H.R. 8882 sought to legislate on family cord blood banking with a focus on taxation but did not progress beyond committee referral and is now expired without detailed public information on its provisions.
- The bill is titled the Family Cord Blood Banking Act and was introduced in the House of Representatives during the 118th Congress.
- It was referred to the House Committee on Ways and Means on June 28, 2024, indicating a focus on tax-related aspects.
- The bill did not advance beyond committee referral and is currently classified as failed or expired.
- No official summary or full text is publicly available, limiting detailed analysis of its content or specific measures.
['Potentially families interested in cord blood banking services if tax provisions were included', 'Cord blood banking industry and related healthcare providers if the bill included supportive tax measures', 'Tax authorities and policymakers involved in healthcare-related tax policy']
["Lack of publicly available full text and official summary limits transparency and understanding of the bill's scope and impact", 'Unclear fiscal impact or cost implications due to absence of detailed provisions', 'Uncertainty about enforcement mechanisms or oversight provisions', 'Potential complexity in tax code changes related to healthcare services']
The bill was introduced during the 118th Congress and referred to the House Committee on Ways and Means, which handles taxation and revenue-related legislation. Its failure to progress beyond committee referral suggests limited legislative momentum or prioritization. The policy area classification as taxation indicates the bill likely involved tax incentives or regulations related to family cord blood banking, a niche healthcare service area. No further legislative actions were recorded.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, tax provisions related to family cord blood banking could influence healthcare spending decisions by families.', 'Potential changes in tax policy might affect the cord blood banking industry’s market dynamics and service offerings.', 'Legislative attention to cord blood banking taxation could prompt further policy discussions on healthcare-related tax benefits.']
The absence of an official summary and full text for H.R. 8882 limits transparency and public oversight. The bill’s referral to the Ways and Means Committee indicates a tax policy focus, but without detailed provisions or cost estimates, it is difficult to evaluate its potential impact or implementation challenges. Monitoring such bills for completeness of public documentation is essential for informed legislative review and accountability.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.